Tekla Capital Management’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-751,905
| Closed | -$3.15M | – | 183 |
|
2022
Q2 | $3.15M | Hold |
751,905
| – | – | 0.12% | 102 |
|
2022
Q1 | $3.75M | Hold |
751,905
| – | – | 0.13% | 103 |
|
2021
Q4 | $5.05M | Hold |
751,905
| – | – | 0.16% | 100 |
|
2021
Q3 | $4.12M | Hold |
751,905
| – | – | 0.13% | 113 |
|
2021
Q2 | $4.92M | Hold |
751,905
| – | – | 0.16% | 119 |
|
2021
Q1 | $6.29M | Hold |
751,905
| – | – | 0.22% | 104 |
|
2020
Q4 | $5.26M | Buy |
751,905
+276,503
| +58% | +$1.94M | 0.18% | 116 |
|
2020
Q3 | $2.97M | Buy |
475,402
+222,223
| +88% | +$1.39M | 0.11% | 133 |
|
2020
Q2 | $1.18M | Hold |
253,179
| – | – | 0.05% | 188 |
|
2020
Q1 | $1.04M | Sell |
253,179
-21,821
| -8% | -$89.9K | 0.05% | 174 |
|
2019
Q4 | $1.58M | Hold |
275,000
| – | – | 0.06% | 160 |
|
2019
Q3 | $1.26M | Hold |
275,000
| – | – | 0.05% | 150 |
|
2019
Q2 | $1.47M | Hold |
275,000
| – | – | 0.06% | 145 |
|
2019
Q1 | $1.72M | Hold |
275,000
| – | – | 0.07% | 138 |
|
2018
Q4 | $2.48M | Hold |
275,000
| – | – | 0.11% | 118 |
|
2018
Q3 | $3.44M | Hold |
275,000
| – | – | 0.12% | 115 |
|
2018
Q2 | $3.78M | Hold |
275,000
| – | – | 0.14% | 106 |
|
2018
Q1 | $5.5M | Hold |
275,000
| – | – | 0.21% | 88 |
|
2017
Q4 | $3.28M | Hold |
275,000
| – | – | 0.13% | 106 |
|
2017
Q3 | $4.22M | Hold |
275,000
| – | – | 0.15% | 93 |
|
2017
Q2 | $3.21M | Buy |
+275,000
| New | +$3.21M | 0.12% | 98 |
|